Oak GLP-1 Review (2026): Pricing, Pros, Cons & Expert Advice

Oak is one of the most aggressively priced telehealth GLP-1 programs in the United States in 2026. Compounded semaglutide starts at $133 per month and compounded tirzepatide at $199 per month — both well below the category average — with one-price-all-dosages structure, no recurring subscription, and free shipping. It's LegitScript certified, runs entirely online, and ships from licensed compounding pharmacies. After spending the better part of a week scrutinizing Oak's pricing, qualification flow, supported medications, and customer feedback, here's our honest take on who it's right for, where it falls short, and whether it deserves a spot at the top of your shortlist.

What is Oak GLP-1?

Oak (legally Oak Longevity) is a U.S. telehealth platform that prescribes and ships compounded GLP-1 medications — primarily semaglutide and tirzepatide — for weight management. Through its website at oaklovesyou.com, Oak connects patients with licensed clinicians who review medical intake forms online, issue prescriptions where appropriate, and arrange direct-to-home medication delivery from partner compounding pharmacies.

The brand positions around three messages that show up everywhere across its marketing: affordability ("Affordable Longevity"), simplicity ("no clinics, no waiting rooms, no hassle"), and biology-first weight loss ("it's not a willpower problem — it's biology"). Oak's pitch is that the same active ingredients found in branded GLP-1 products like Wegovy, Ozempic, Zepbound, and Mounjaro are available through its program at a meaningful discount.

Oak is LegitScript certified — a third-party verification confirming the operation meets baseline regulatory and safety standards for online pharmacy and telehealth services. The brand reports serving over 10,000 patients and its clinic line is published as 435-244-7757.

How Oak works (the 3-step process)

Oak's enrollment flow mirrors the standard telehealth GLP-1 playbook — gather information online, route to a licensed clinician, dispatch medication once approved. The brand markets this as three steps:

1. Answer a few questions. A short online intake covers health goals, medical history, current medications, allergies, and basic biometrics. This is the foundation a clinician needs to evaluate eligibility.
2. A doctor reviews your information. A licensed clinician — backed by Oak's care team and health coaches — assesses the submission. If you're clinically appropriate, they issue a prescription with a specific medication and starting dose. If not, Oak says they'll communicate that decision.
3. Medication ships to your door. Free home delivery in days with tracking. Patient support is included throughout the titration period at no additional charge.

What's worth flagging about Oak's process versus competitors: no in-person component (no labs at signup based on public-facing materials), no upfront consultation fee before clinician review, and the explicit absence of a recurring subscription. You pay per shipment, not per month.

One-price-all-dosages billing combined with no-subscription pricing makes Oak unusually friendly to patients who want to titrate up without watching their monthly cost balloon. — Bartley Editorial Analysis

Who Oak GLP-1 is best for (and who should look elsewhere)

Oak is a good fit if you:

• Want among the lowest-priced GLP-1 programs available in the U.S. telehealth market
• Prefer a fully online process with home delivery and no in-person visits
• Are open to compounded medications (versus only branded GLP-1 products)
• Want medical support that extends beyond diet and exercise alone
• Dislike subscription lock-in and prefer one-shipment-at-a-time billing

Oak is not a fit if you:

• Are under 18 years old
• Are currently pregnant or nursing
• Have a BMI under 22 with no relevant comorbidities
• Require a branded medication (Wegovy, Ozempic, Zepbound, Mounjaro) — Oak's lineup is compounded only
• Need extensive in-person clinical oversight or have complex comorbidities
• Have a known hypersensitivity to GLP-1 medications or a personal/family history of medullary thyroid carcinoma or MEN2

Oak adds that if you're unsure, their clinicians will review your health profile and tell you whether treatment is appropriate — meaning a denial is also a valid outcome.

Oak GLP-1 pricing in 2026 (full breakdown)

Pricing is where Oak's value proposition lives or dies — and it's the question we get most from readers. Here's what Oak's public-facing rate sheet looks like at the time of this review:

Three pricing details that meaningfully differentiate Oak from typical telehealth GLP-1 competitors:

• One price, all dosages. Unlike providers that ladder pricing up with each titration step, Oak charges a flat rate regardless of where you are in the dose schedule.
• No subscriptions. You order what you need when you need it. There's no auto-billed recurring charge and no cancellation hoops.
• Free shipping is actually free. Some competitors quote a low monthly rate but tack on $25–$50 of "medical handling" fees. Oak's pricing is what you see.

Medications Oak offers

Oak's lineup focuses on compounded GLP-1 receptor agonists, with adjacent peptide and wellness offerings. Here's what's available:

• Compounded semaglutide — the active ingredient also found in branded Wegovy and Ozempic. Used for chronic weight management in eligible adults.
• Compounded tirzepatide — the active ingredient also found in branded Zepbound and Mounjaro. A dual GIP/GLP-1 receptor agonist increasingly favored for its weight-loss profile.
• Oral GLP-1 — a tablet option for patients who prefer not to self-inject.
• NAD+ & Glutathione — longevity-focused offerings.
• PT-141 (Bremelanotide) — Oak's women's health offering.
• Tadalafil — Oak's men's health offering.
• Sermorelin Peptides — growth hormone-releasing peptide.

Compounded vs branded — what to know

Oak's GLP-1 lineup is exclusively compounded. Compounded medications are prepared by state-licensed compounding pharmacies and contain the same active ingredient as the branded product, but they are not FDA-approved as finished drug products in the way Wegovy or Zepbound are. If you specifically need a branded GLP-1 product, Oak is not the right choice. If you're open to compounded options and prioritize cost, Oak's pricing is hard to beat.

Side effects & safety

GLP-1 medications — whether prescribed through Oak or any other provider — carry a well-characterized side-effect profile. The most commonly reported effects include:

• Gastrointestinal effects: nausea, vomiting, diarrhea, constipation, abdominal pain. Typically dose-dependent and most prominent during early titration.
• Reduced appetite and earlier satiety — part of the medication's mechanism but can feel unusual at first.
• Fatigue, headache, dizziness — especially during the first few weeks.
• Injection-site reactions — mild irritation, redness, or tenderness with subcutaneous injections.

Less common but more serious effects can include pancreatitis, gallbladder issues, kidney problems, and severe allergic reactions. GLP-1 medications carry a boxed warning related to thyroid C-cell tumors based on animal studies — patients with a personal or family history of medullary thyroid carcinoma or MEN2 should not use them.

What the Oak signup experience actually looks like

The intake flow has a few practical characteristics worth knowing about:

• The questionnaire covers standard medical history, current medications, allergies, biometrics, and weight-loss goals.
• You'll be asked about contraindications — pregnancy status, history of pancreatitis, thyroid history — and a misleading answer can put you at real risk, so be candid.
• The clinician review is asynchronous (not a live video call) for most patients.
• Once approved, medication is dispatched from the partner pharmacy with tracking, typically within a few business days.
• Refills and dose adjustments are handled by messaging the care team — no re-enrollment.

Two friction points worth flagging: support is not 24/7 (a Saturday side-effect question may not get a same-day answer), and state availability can shift based on pharmacy network. Confirm Oak ships to your state before getting deep into the intake.

Oak GLP-1 pros and cons

What real Oak patients are saying

Aggregating publicly available patient feedback paints a consistent picture: satisfaction clusters around the value proposition (cost, ease of signup, fast delivery) and complaints cluster around responsiveness (delayed message replies during peak periods, occasional refill timing issues).

Positive themes appearing repeatedly across third-party platforms:

• Onboarding speed — many patients move from intake to medication in hand within a week
• Doctors and care team described as approachable and prompt for most patients
• Cost relative to outcomes — "I can't believe it's only $133" sentiment is common
• Convenience of skipping in-person clinic visits

Critical themes worth weighing:

• Support response time can lag during high-volume promotional periods
• Occasional reports of refill timing and shipment scheduling friction
• Patients who expected branded medications occasionally report disappointment after realizing the compounded-only model

"Everything about the process with Oak is easy. The doctors message promptly and the customer service is amazing." — Oak patient testimonial collected by the brand.

Oak vs the alternatives

Here's how Oak stacks up against the other telehealth GLP-1 providers we cover. Pricing reflects each provider's lowest published starting tier as of May 2026 — confirm on the official site before deciding.

If cost is your primary decision driver and you're open to compounded medications, Oak is hard to beat. If you weight extensive clinician access or branded medication availability higher, compare Oak directly against the alternatives — see our independent reviews of Medvi, TrimRx, and DirectMeds.

Oak GLP-1 frequently asked questions

Final verdict: should you choose Oak?

If your priority is the most affordable legitimate telehealth GLP-1 program in the United States, Oak is one of the clearest answers in 2026. The $133 semaglutide starting price, $199 tirzepatide starting price, flat-rate-across-dosages structure, no-subscription model, LegitScript certification, and free shipping combine to make a compelling value proposition for a specific kind of patient.

That patient is someone who wants a straightforward, no-frills, online-only GLP-1 program; is comfortable with compounded medications; does not require extensive in-person clinical infrastructure; and is willing to communicate with their clinician asynchronously. For that profile, Oak's pricing is genuinely difficult to beat.

Where Oak is less of a fit: patients who specifically need branded medications, anyone with complex comorbidities requiring high-touch specialty oversight, or buyers who place a premium on 24/7 support access.

For most cost-sensitive readers we hear from, Oak deserves a serious look. The $50-off new-patient offer lowers the trial cost further, and the no-subscription structure means there's no auto-billing trap if it isn't the right fit.

Published: May 26, 2026 · Last updated: May 26, 2026 · Spot a factual issue? Tell our editors.